Losses on bond portfolio behind net profit… … as indicated in net profit downgrade in October Core o...
Q3-rapporten Nettoomsättning för Q3 uppgick till 18,5 mkr (15,4) med ett rörelseresultat för kvartal...
Redeye endorses Saniona’s pre-clinical progress with drug candidate SAN903, that has compelling anti...
Redeye’s expectations were outdone by a wide margin.
Redeye comments on Stillfront’s announcement that it is evaluating closing down its subsidiary Ulka ...
Redeye saw sales substantially lower than our expectations for the quarter.
NOI increased 10% y-o-y, 1% vs ABGSCe Income from property management -7% vs.
Exel’s Q3 results came in soft relative to our estimates.
Redeye comments on yesterday’s news from Tessin, where the company announced a rights issue which, i...
Oceantech-bolaget Resqunit ska påbörja leverans av dess första order under mitten av november som fo...
Aspo achieved again very high profitability, this time even with Russia mostly neutralized.
Marimekko's Q3 growth was solid although EBIT fell short of our expectations.
Q3 weakness likely to persist into Q4-Q1’23e Recoveries in Q2-Q3’23e indicates clear improvements EP...
Redeye updates its estimates following Alelion’s Q3 2022 report, where the main events were the orde...
Q3 net sales were 11% above Refinitiv consensus. A strong shipping market, raw material prices and a...
ARR når våra helårsestimat ARR uppgick till 152 mkr vilket motsvarar en tillväxt om 88%, varav 34% v...
Revenues were 11% above Refinitiv consensus in Q3. Clean operating profit of EUR 13m was EUR 2.
Redeye raises its estimates but maintains its fair value range unchanged on the back of the Q3 repor...
Aspo’s Q3 results topped estimates. In our view the beat was driven by ESL, where Q3 was again a ver...
Redeye comments on Beyond Frames order of SEK1.3m from a Chinese company.
